Capitol Hill Briefing: Personalized Medicine and Responsible Access to Pain Medication

Personalized Medicine and Responsible Access to Pain Medication:
A Capitol Hill Briefing

AGENDA

10AM: Welcome

            Peter Pitts, Center for Medicine in the Public Interest

11:00: Access to Pain Medications: The Role of Patients and Manufacturers
            Moderator: Steve Usdin, BioCentury
            Cindy Steinberg, US Pain Foundation
            Bob Twillman, American Academy of Pain Management
            Stuart Kim, Mallinckrodt Pharmaceuticals
 
12:00: Issue: Pain Medications: Two Reporters Views

            Moderator: Peter Pitts, CMPI
            Steve Usdin, BioCentury
            Judy Foreman, Syndicated Columnist

1:30:    Closing Keynote: Pain Medications and the Future of Personalized       Medicine

            Introduction: Peter Pitts, CMPI
            Charles Inturrisi, Weill Cornell Medical Center
 
2:15: Closing Remarks
 
Peter Pitts, Center for Medicine in the Public Interest
Sign Up for Our Email Newsletter

RECENT NEWS

Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent

Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent

Waiving patent protection discourages cutting-edge research investments, which in turn produce breakthrough treatments no...  Read more

'I'm hopeful for the future': Alzheimer's drug approved by FDA

'I'm hopeful for the future': Alzheimer's drug approved by FDA

Peter Pitts of CMPI and Dr. Ronald Petersen of the Mayo Clinic discuss the FDA's approval of aducanumab...  Read more

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilars bring lower costs and greater access to the market for biological products, but FDA must determine a predicta...  Read more

DRUGWONKS BLOG